Target intelligence / Profile preview

High-affinity immunoglobulin E receptor (FcεRI) complex (FcεRI)

Target
FcεRI
Molecular classification
Receptor, Immunoglobulin superfamily, Multi-subunit immune recognition receptor, Other
01

Overview

The High-affinity immunoglobulin E receptor (FcεRI) complex is a multi-subunit protein assembly found on the surface of mast cells, basophils, and dendritic cells that plays a central role in the allergic immune response [PubMed: 10359118]. On mast cells and basophils, the complex typically consists of an alpha chain, a beta chain, and two disulfide-linked gamma chains, whereas on dendritic cells, it exists in a trimeric alpha-gamma-2 form [UniProt: P12319]. The alpha subunit is responsible for binding the Fc region of IgE with high affinity; when allergens cross-link these IgE-bound receptors, it triggers the release of inflammatory mediators like histamine and leukotrienes [StatPearls: NBK538261]. This signaling cascade is mediated by intracellular kinases such as Spleen tyrosine kinase (SYK) and Bruton's tyrosine kinase (BTK) [PubMed: 24011515]. Therapeutic interventions like Omalizumab target the IgE molecule to prevent the formation of the complex, thereby reducing receptor density and cellular reactivity in conditions such as asthma and chronic urticaria [DrugBank: DB00043]. Additionally, small molecule inhibitors targeting the downstream signaling components of the complex are being developed to treat various IgE-mediated disorders.

Other names
Fc epsilon RIFCER1High-affinity IgE receptorIgE-FcεRI complexIgE–FcεRI complex on mast cells, basophils, and dendritic cells
02

Mechanism of action

Monoclonal antibodies sequester free IgE to prevent its binding to the receptor, while small molecules inhibit downstream signaling kinases like BTK and SYK activated by the complex.

03

Biological functions

Immune responseSignal transductionCell degranulationCytokine productionAntigen presentationOther
04

Disease associations

InflammationAsthmaAllergic rhinitisChronic spontaneous urticariaAtopic dermatitisAnaphylaxisOther
05

Safety considerations

Risk of anaphylaxisHypersensitivity reactionsPotential for increased susceptibility to helminth infectionsInjection site reactions
06

Interacting drugs

Omalizumab

5 more in the full profile.

07

Biomarkers

Total serum IgESurface FcεRI expressionBasophil activation markers (CD63, CD203c)Skin prick test reactivity

Beyond the preview

Go deeper on High-affinity immunoglobulin E receptor (FcεRI) complex (FcεRI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High-affinity immunoglobulin E receptor (FcεRI) complex (FcεRI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call